Assessment of factors associated with pre-diabetes in HCV infection including direct and dynamic measurements of insulin action

Journal of Viral Hepatitis

Volumn 19, Issue 7, 2012, Pages 480-487

  Mukhtar, N A ^a   Ayala, C ^a   Maher, J J ^a,b   Khalili, Mandana ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic hepatitis C virus infection; Impaired fasting glucose; Impaired glucose tolerance; Insulin resistance; Insulin secretion; Liver inflammation

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; CAUCASIAN; CLINICAL ASSESSMENT; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEPATITIS; HEPATITIS C; HISPANIC; HUMAN; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RACE DIFFERENCE; STEADY STATE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; BODY MASS INDEX; DIABETES MELLITUS; ETHNIC GROUPS; FEMALE; GLUCOSE TOLERANCE TEST; HEPATITIS C; HUMANS; INSULIN; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 84862193200     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2011.01568.x     Document Type: Article

References (26)

1. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49(4): 1335-1373.
2. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133(8): 592-599.
3. Karve A, Hayward RA. Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.S. adults. Diabetes Care 2010; 33(11): 2355-2359.
4. Levitan EB, Song Y, Ford ES, Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 2004; 164(19): 2147-2155. (Pubitemid 39410805)
5. Hui JM, Sud A, Farrell GC et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology 2003; 125(6): 1695-1704. (Pubitemid 37500434)
6. Romero-Gomez M, Del Mar Viloria M, Andrade RJ et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 2005; 128(3): 636-641. (Pubitemid 40585366)
7. Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl 2004; 10(3): 349-355. (Pubitemid 38380307)
8. Nathan DM, Davidson MB, DeFronzo RA et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007; 30(3): 753-759. (Pubitemid 46354366)
9. Abdul-Ghani MA, DeFronzo RA. Plasma glucose concentration and prediction of future risk of type 2 diabetes. Diabetes Care 2009; 32(Suppl. 2): S194-S198.
10. Grasso A, Malfatti F, De Leo P et al. Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin. J Hepatol 2009; 51(6): 984-990.
11. Lam KD, Bacchetti P, Abbasi F et al. Comparison of surrogate and direct measurement of insulin resistance in chronic hepatitis C virus infection: impact of obesity and ethnicity. Hepatology 2010; 52(1): 38-46.
12. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26(Suppl. 1): S5-S20.
13. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995; 19(12): 1409-1417.
14. McLaughlin T, Deng A, Gonzales O et al. Insulin resistance is associated with a modest increase in inflammation in subcutaneous adipose tissue of moderately obese women. Diabetologia [Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural]. 2008; 51(12): 2303-2308.
15. Phillips DI, Clark PM, Hales CN, Osmond C. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 1994; 11(3): 286-292. (Pubitemid 24144145)
16. Harris MI, Flegal KM, Cowie CC et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998; 21(4): 518-524. (Pubitemid 28172927)
17. Festa A, D'Agostino Jr R, Hanley AJ, Karter AJ, Saad MF, Haffner SM. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 2004; 53(6): 1549-1555. (Pubitemid 38697668)
18. Hsu CS, Liu CJ, Liu CH et al. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C. Liver Int 2008; 28(2): 271-277. (Pubitemid 351201041)
19. Fartoux L, Poujol-Robert A, Guechot J, Wendum D, Poupon R, Serfaty L. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut 2005; 54(7): 1003-1008. (Pubitemid 40873917)
20. Kawaguchi T, Yoshida T, Harada M et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004; 165(5): 1499-1508. (Pubitemid 39435150)
21. Aytug S, Reich D, Sapiro LE, Bernstein D, Begum N. Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology 2003; 38(6): 1384-1392. (Pubitemid 37466964)
22. Shintani Y, Fujie H, Miyoshi H et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004; 126(3): 840-848. (Pubitemid 38298332)
23. Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006; 29(5): 1130-1139. (Pubitemid 44115261)
24. Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes 2006; 55(5): 1430-1435. (Pubitemid 44195383)
25. Hanefeld M, Koehler C, Fuecker K, Henkel E, Schaper F, Temelkova- Kurktschiev T. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Diabetes Care 2003; 26(3): 868-874. (Pubitemid 36929357)
26. Weyer C, Bogardus C, Pratley RE. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 1999; 48(11): 2197-2203. (Pubitemid 29521850)